-+ 0.00%
-+ 0.00%
-+ 0.00%

Oppenheimer Maintains Outperform on Rentokil Initial, Raises Price Target to $35

Benzinga·03/10/2026 14:20:38
Listen to the news
Oppenheimer analyst Ian Zaffino maintains Rentokil Initial (NYSE:RTO) with a Outperform and raises the price target from $30 to $35.